Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 24810480)


Clinical features and outcomes of influenza infections in lung transplant recipients: a single-season cohort study.

Schuurmans MM, Isenring BD, Jungo C, Boeni J, Mueller NJ, Kohler M, Benden C.

Transpl Infect Dis. 2014 Jun;16(3):430-9. doi: 10.1111/tid.12228. Epub 2014 May 9.


Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.

Ryoo SM, Kim WY, Sohn CH, Seo DW, Oh BJ, Lee JH, Lee YS, Lim KS.

Influenza Other Respir Viruses. 2013 Sep;7(5):833-7. doi: 10.1111/irv.12065. Epub 2012 Dec 26.


Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.

Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, Win NN, Chan M, Lim PL, Lee CC, Leo YS.

Clin Infect Dis. 2010 Apr 1;50(7):963-9. doi: 10.1086/651083.


Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.

Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, Guo X, Zheng Y, van Doorn HR, Farrar J, Gao Z, Feng Z, Wang Y, Yang W.

BMJ. 2010 Sep 28;341:c4779. doi: 10.1136/bmj.c4779.


Outcome of influenza infection managed with oseltamivir in lung transplant recipients.

Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC.

J Heart Lung Transplant. 2008 Mar;27(3):282-8. doi: 10.1016/j.healun.2007.11.575.


Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA.

Lancet Infect Dis. 2014 Feb;14(2):109-18. doi: 10.1016/S1473-3099(13)70267-6. Epub 2013 Nov 22.


H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.

Souza TM, Salluh JI, Bozza FA, Mesquita M, Soares M, Motta FC, Pitrowsky MT, de Lourdes Oliveira M, Mishin VP, Gubareva LV, Whitney A, Rocco SA, Gonçalves VM, Marques VP, Velasco E, Siqueira MM.

PLoS One. 2010 Nov 30;5(11):e14158. doi: 10.1371/journal.pone.0014158.


The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.

Li IW, Hung IF, To KK, Chan KH, Wong SS, Chan JF, Cheng VC, Tsang OT, Lai ST, Lau YL, Yuen KY.

Chest. 2010 Apr;137(4):759-68. doi: 10.1378/chest.09-3072. Epub 2010 Jan 8.


Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.

Wang YG, Jiang M, Wang RB, Zha QL, Zhang SJ, Zhou GQ, Li XW, Wang YY, Lv AP.

J Tradit Chin Med. 2012 Jun;32(2):148-55.


Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.

Khanna N, Steffen I, Studt JD, Schreiber A, Lehmann T, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch HH.

Transpl Infect Dis. 2009 Apr;11(2):100-5. doi: 10.1111/j.1399-3062.2008.00362.x. Epub 2009 Jan 20.


Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.

Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DK, Cheng CK, Uyeki TM, Houck PM, Malik Peiris JS, Leung GM.

Clin Infect Dis. 2010 Mar 1;50(5):707-14. doi: 10.1086/650458.


Duration of viral shedding in hospitalized patients infected with pandemic H1N1.

Meschi S, Selleri M, Lalle E, Bordi L, Valli MB, Ferraro F, Ippolito G, Petrosillo N, Lauria FN, Capobianchi MR.

BMC Infect Dis. 2011 May 23;11:140. doi: 10.1186/1471-2334-11-140.


Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients.

Giannella M, Alonso M, Garcia de Viedma D, Lopez Roa P, Catalán P, Padilla B, Muñoz P, Bouza E.

Clin Microbiol Infect. 2011 Aug;17(8):1160-5. doi: 10.1111/j.1469-0691.2010.03399.x. Epub 2010 Dec 3.


A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.

Ison MG, Hui DS, Clezy K, O'Neil BJ, Flynt A, Collis PJ, Simon TJ, Alexander WJ.

Antivir Ther. 2013;18(5):651-61. doi: 10.3851/IMP2442. Epub 2012 Oct 30.


Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients.

Tran D, Science M, Dix D, Portwine C, Zelcer S, Johnston DL, Yanofsky R, Gassas A, Ethier MC, Sung L.

Influenza Other Respir Viruses. 2012 Nov;6(6):e105-13. doi: 10.1111/j.1750-2659.2012.00352.x. Epub 2012 Mar 14.


Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.

Viasus D, Paño-Pardo JR, Pachón J, Riera M, López-Medrano F, Payeras A, Fariñas MC, Moreno A, Rodríguez-Baño J, Oteo JA, Ortega L, Torre-Cisneros J, Segura F, Carratalà J; Novel Influenza A(H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI).

Chest. 2011 Oct;140(4):1025-32. doi: 10.1378/chest.10-2792. Epub 2011 Mar 17.


Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, Chu IM, Lai RW, Cockram CS, Sung JJ.

J Infect Dis. 2009 Aug 15;200(4):492-500. doi: 10.1086/600383.


Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.

Antón A, López-Iglesias AA, Tórtola T, Ruiz-Camps I, Abrisqueta P, Llopart L, Marcos MÁ, Martínez MJ, Tudó G, Bosch F, Pahissa A, de Anta MT, Pumarola T.

Diagn Microbiol Infect Dis. 2010 Nov;68(3):214-9. doi: 10.1016/j.diagmicrobio.2010.08.003.


Factors associated with early hospital discharge of adult influenza patients.

Lee N, Chan PK, Choi KW, Lui G, Wong B, Cockram CS, Hui DS, Lai R, Tang JW, Sung JJ.

Antivir Ther. 2007;12(4):501-8.


Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M.

Clin Infect Dis. 2009 Feb 15;48(4):389-96. doi: 10.1086/596311.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk